Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity

Area of Science:

• Immunology
• Neuroendocrinology

Background:

• Opioid peptides circulate in human peripheral blood.
• These peptides may interact with human lymphocytes.

Purpose of the Study:

• To investigate the influence of endogenous opioid peptides on human lymphocyte natural killer (NK) function.
• To determine if opioid peptides play a physiological role in regulating NK cell activity.

Main Methods:

• Studied the effect of beta-endorphin and its analogues on human peripheral blood NK function.
• Administered varying doses of opioid peptides and observed dose-dependent responses.
• Utilized naloxone, an opiate antagonist, to assess reversibility of NK function enhancement.
• Compared the efficacy of different beta-endorphin analogues, including beta-lipotropin, gamma-endorphin, Leu-enkephalin, and -endorphin.

Main Results:

• Beta-endorphin and analogues (e.g., gamma-endorphin) significantly enhance human peripheral blood NK function.
• The enhancement of NK activity by opioid peptides was dose-dependent.
• Naloxone administration reversed the NK-enhancing effects of these peptides.
• Beta-lipotropin and gamma-endorphin were 3-5 times more potent than Leu-enkephalin and -endorphin in enhancing NK function.
• Naloxone also reversed NK enhancement mediated by human fibroblast interferon.

Conclusions:

• Circulating endogenous opioid peptides appear to modulate human lymphocyte NK function.
• These findings suggest a physiological role for opioid peptides in the regulation of natural killing.
• Opioid peptides may represent a link between the neuroendocrine and immune systems in regulating immune responses.